Piracetam

(Last updated 4 December 2024)

Embedded image

Figure . The molecular diagram of piracetam.

CSP studies

Harriott’s paper noted that the gas phase optimized conformation did not produce crystal structures that were energetically competitive. However, she did not store the intramolecular energy penalties in the .conf files (and the method was not consistent with the paper). Single point energies of each conformation (as extracted from a .res file) coupled with an unconstrained gas phase optimization starting from somewhere close to the conformation described in the paper gave intramolecular energies consistent with the information given in the SI. Hence the values and computational method from Harriott’s paper were added to the .conf files before reuploading.

REFCODEBISMEV
FormulaC6 H10 N2 02
Common NamePiracetam
IUPAC Systematic Name2-Oxo-1-pyrrolidinylacetamide
CSD RefcodesBISMEV05, BISMEV11, BISMEV12, BISMEV04, BISMEV08
ScientistHarriott Nowell
Date2005
PublicationNowell H, Price SL, Acta Cryst B, 61, 558-568 (2005) DOI: Open paper (10.1107/s0108768105018549)
Study IdentifierA
Energy Model1
Study_ID0
ProgramsMOLPAK, DMAREL (4.1.1)
Location on S DriveCHEMISTRY_CPOSS\\0-EarlySearches\\home\\louise_price.eminerals\\piracetam
Potential DescriptionFIT

Embedded image

Figure . Crystal energy landscape of piracetam from previous work.

CSD structures (CSD version 5.45 with Mar, Jun and Sep 2024 updates)

Table . Crystallographic information for CSD entries for piracetam. Different polymorphs are coloured differently.

REFCODEspace groupZ’a / Åb / Åc / Åα / °β / °γ / °density / g cm-3Form
BISMEVP-116.4036.6188.55679.85102.3991.091.355II
BISMEV01P21/n16.5256.4416.4639092.19901.366III
BISMEV02P21/n116.4036.4176.5049092.05901.38III
BISMEV03P21/n16.74713.4188.099099.01901.305I
BISMEV04P21/c18.95375.454113.6190104.93901.47IV
BISMEV05P21/n16.725413.25728.05299098.603901.33I
BISMEV06P-116.3216.55978.3879.82102.3490.941.413II
BISMEV07P-116.4426.3538.73781.43112.8891.381.45V
BISMEV08P-116.39036.29328.64581.106113.6891.2951.502V
BISMEV09P-116.2636.20638.41280.77114.6991.121.612V
BISMEV10P-116.1696.16028.28780.41115.3391.151.685V
BISMEV11P-116.3536.52788.371680.29778.22689.0481.409II
BISMEV12P21/n16.45396.385716.18149092.057901.417P21/n
BISMEV13P21/n16.5036.41816.4169092.087901.379III
BISMEV14P2126.5056.41816.4239092.17901.378III

Table . Experimental information for CSD entries for piracetam.

REFCODEspace groupR factorT / KYearComments
BISMEVP-15.82951982Slow cooling of a saturated solution in 2-propanol. Concomitant with BISMEV011
BISMEV01P21/n6.42951982Slow cooling of a saturated solution in 2-propanol. Concomitant with BISMEV1
BISMEV02P21/n4.92951983Not available online
BISMEV03P21/n32951995From powder. From mixed triclinic and monoclinic phases (BISMEV and BISMEV01?), sample heated to 410 K and quenched to room temperature.2
BISMEV04P21/c5.2629320056 M aqueous solution of piracetam loaded into diamond anvil cell. Pressurised to 0.4 GPa, when microcrystals appeared. Temperature cycling around 323 K and cooling to 293 K gave single crystal. Data collection within he diamond anvil cell under pressure.3
BISMEV05P21/n4.191502005Disorder in ring. Heating to 400 K, cooling to 298 K, coating with oil and rapidly cooling to 150 K.3
BISMEV06P-111.492932007Synchrotron @ 0.45 GPa. Slow evaporation of saturated solutions in either 2-propanol or 1,4-dioxane.4
BISMEV07P-18.812932007Synchrotron @ 0.7 GPa. Pressurizing Form II in DAC.4
BISMEV08P-18.012932007Synchrotron @ 0.9 GPa. Pressurizing Form II in DAC.4
BISMEV09P-18.822932007Synchrotron @ 2.5 GPa. Pressurizing Form II in DAC.4
BISMEV10P-19.152932007Synchrotron @ 4.0 GPa. Pressurizing Form II in DAC.4
BISMEV11P-12.271002011Slow evaporation of supersaturated solutions in 2-propanol.5
BISMEV12P21/n2.591002011Slow evaporation of supersaturated solutions in methanol.5
BISMEV13P21/n3.452902011Slow evaporation in a solution of dichloromethane.6
BISMEV14P2110.912982015Synchrotron. From methanol solution (something about chips).7

Other notes

Sally met someone somewhere who has a new form. They will contact me at some stage.

1. G. Admiraal, J. C. Eikelenboom and A. Vos, Acta Crystallographica Section B-Structural Science, 1982, 38, 2600-2605.

2. D. Louer, M. Louer, A. V. Dzyabchenko, V. Agafonov and R. Ceolin, Acta Crystallographica Section B - Structural Science, 1995, 51, 182-187.

3. F. P. A. Fabbiani, D. R. Allan, S. Parsons and C. R. Pulham, CrystEngComm, 2005, 7, 179-186.

4. F. P. A. Fabbiani, D. R. Allan, W. I. F. David, A. J. Davidson, A. R. Lennie, S. Parsons, C. R. Pulham and J. E. Warren, Crystal Growth & Design, 2007, 7, 1115-1124.

5. M.-H. Chambrier, N. Bouhmaida, F. Bonhomme, S. Lebègue, J.-M. Gillet, C. Jelsch and N. E. Ghermani, Crystal Growth & Design, 2011, 11, 2528-2539.

6. A. Tilborg, D. Jacquemin, B. Norberg, E. Perpete, C. Michaux and J. Wouters, Acta Crystallographica Section B, 2011, 67, 499-507.

7. E. M. Horstman, S. Goyal, A. Pawate, G. Lee, G. G. Z. Zhang, Y. Gong and P. J. A. Kenis, Crystal Growth & Design, 2015, 15, 1201-1209.

Dataset downloads